NCT04196179View on ClinicalTrials.gov

ANG-3070 in Healthy Adult Participants

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 17, 2019

Primary Completion Date

November 27, 2020

Study Completion Date

March 10, 2021

Conditions

Healthy Volunteers

Interventions

DRUG

ANG3070

ANG-3070 drug product is a an immediate release oral solid. The drug product consists of a Size 00 Swedish orange capsule containing drug substance (10 mg, 50 mg, or 250 mg) with no excipients.

DRUG

Placebo oral capsule

ANG-3070 placebo capsules visually match the drug product.

Trial Locations (1)

3004

Nucleus Network, VIC, Melbourne